Safety monitor fear, drug trials20th March 2008
Experts say that more needs to be done to monitor safety during drug trials on children.
A team from Nottingham University looked at 739 trials and found that only 2% of them had set up independent safety monitoring committees with the others relying on internal monitoring. Writing in the journal Acta Paediatrica, the researchers said this was â€œunacceptableâ€? and that independent oversight was essential.
However, the Association of the British Pharmaceutical Industry said that the procedures which were currently used were adequate.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Safety monitor fear, drug trials
Author: Mark Nicholls
Article Id: 6067
Date Added: 20th Mar 2008